Literature DB >> 22753300

X-linked adrenoleukodystrophy presenting as Addison's disease.

Bernhard Kaspar Morell1, Jens Teichler, Kemal Budak, Jörg Vollenweider, Vojtech Pavlicek.   

Abstract

We report the case of a young man with a history of attention deficit/hyperactivity disorder and mild cognitive impairment who presented with chronic fatigue, anorexia and progressive darkening of the skin. On laboratory testing, severely depressed concentrations of morning cortisol, along with highly elevated values of adrenocorticotropic hormone (ACTH) revealed primary adrenal insufficiency as the primary cause of the patient's symptomatology. Imaging of the brain showed altered signal intensities in the parieto-occipital regions of the brain. The demonstration of increased very long chain fatty acids (VLCFA) established the diagnosis of adolescent X-linked adrenoleukodystrophy (X-ALD). Presenting at an advanced yet slowly progressive stage the patient was not a suitable candidate for haematopoietic stem cell transplantation (HSCT), and treatment focused on hormone replacement therapy, family counselling and supportive care. On follow-up visits within the following year, fatigue had diminished and there was no evidence of progressive neurological deficits. However, exacerbation of the psychiatric symptomatology resulted in admittance to a psychiatric ward.

Entities:  

Mesh:

Year:  2010        PMID: 22753300      PMCID: PMC3047513          DOI: 10.1136/bcr.11.2009.2419

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

Review 1.  Adrenal insufficiency.

Authors:  W Oelkers
Journal:  N Engl J Med       Date:  1996-10-17       Impact factor: 91.245

Review 2.  Adrenoleukodystrophy: biochemical procedures in diagnosis, prevention and treatment.

Authors:  P A Watkins; S Naidu; H W Moser
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

Review 3.  Adrenoleukodystrophy: frequency of presentation as a psychiatric disorder.

Authors:  W Kitchin; S A Cohen-Cole; S F Mickel
Journal:  Biol Psychiatry       Date:  1987-11       Impact factor: 13.382

4.  [Adrenomyeloneuropathy, a rare cause of primary adrenal cortex insufficiency].

Authors:  K Frank; O Schrecker; K Brosi; K H Krause; P Vescei; H W Moser; R Ziegler
Journal:  Dtsch Med Wochenschr       Date:  1986-10-03       Impact factor: 0.628

5.  Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita.

Authors:  A T Reutens; J C Achermann; M Ito; M Ito; W X Gu; R L Habiby; P A Donohoue; S Pang; P C Hindmarsh; J L Jameson
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

6.  A missense point mutation (Ser515Phe) in the adrenoleukodystrophy gene in a family with adrenomyeloneuropathy: a clinical, biochemical, and genetic study.

Authors:  M Vorgerd; S Fuchs; M Tegenthoff; J P Malin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

7.  Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999.

Authors:  Charles Peters; Lawrence R Charnas; Ye Tan; Richard S Ziegler; Elsa G Shapiro; Todd DeFor; Satkiran S Grewal; Paul J Orchard; Susan L Abel; Anne I Goldman; Norma K C Ramsay; Kathryn E Dusenbery; Daniel J Loes; Lawrence A Lockman; Shunichi Kato; Patrick R Aubourg; Hugo W Moser; William Krivit
Journal:  Blood       Date:  2004-04-08       Impact factor: 22.113

Review 8.  Adrenoleukodystrophy: phenotypic variability and implications for therapy.

Authors:  H W Moser; A B Moser; K D Smith; A Bergin; J Borel; J Shankroff; O C Stine; C Merette; J Ott; W Krivit
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

9.  X-linked adrenoleukodystrophy in patients with idiopathic Addison disease.

Authors:  P Jorge; D Quelhas; P Oliveira; R Pinto; A Nogueira
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

10.  Eighty-six cases of Addison's disease.

Authors:  M F Kong; W Jeffcoate
Journal:  Clin Endocrinol (Oxf)       Date:  1994-12       Impact factor: 3.478

View more
  1 in total

1.  Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible.

Authors:  Christiane Theda; Katy Gibbons; Todd E Defor; Pamela K Donohue; W Christopher Golden; Antonie D Kline; Fizza Gulamali-Majid; Susan R Panny; Walter C Hubbard; Richard O Jones; Anita K Liu; Ann B Moser; Gerald V Raymond
Journal:  Mol Genet Metab       Date:  2013-11-09       Impact factor: 4.797

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.